Meeting ReportMolecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Neuroimaging
Novel PET radioligand [18F]PF-06445974 targets PDE4B, and its uptake is rapidly increased by LPS-induced neuroinflammation compared to TSPO radioligand [11C]ER176
Paul Parcon, Raven Cureton, Mia Scrabis, Carson Knoer, Sami Zoghbi, Cheryl Morse, Jeih-San Liow, Shawn Wu, Victor Pike and Robert Innis
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 241480;
Paul Parcon
1National Institute of Mental Health
Raven Cureton
2NIMH Intramural Research Program
Mia Scrabis
2NIMH Intramural Research Program
Carson Knoer
3National Institutes of Mental Health
Sami Zoghbi
4NIMH
Cheryl Morse
Jeih-San Liow
5NIH/NIMH
Shawn Wu
1National Institute of Mental Health
Victor Pike
6Molecular Imaging Branch, NIMH, NIH
Robert Innis
1National Institute of Mental Health
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
Novel PET radioligand [18F]PF-06445974 targets PDE4B, and its uptake is rapidly increased by LPS-induced neuroinflammation compared to TSPO radioligand [11C]ER176
Paul Parcon, Raven Cureton, Mia Scrabis, Carson Knoer, Sami Zoghbi, Cheryl Morse, Jeih-San Liow, Shawn Wu, Victor Pike, Robert Innis
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241480;
Novel PET radioligand [18F]PF-06445974 targets PDE4B, and its uptake is rapidly increased by LPS-induced neuroinflammation compared to TSPO radioligand [11C]ER176
Paul Parcon, Raven Cureton, Mia Scrabis, Carson Knoer, Sami Zoghbi, Cheryl Morse, Jeih-San Liow, Shawn Wu, Victor Pike, Robert Innis
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 241480;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.